The majority of pulmonary hypertension (PH) patients are female. The reason why that is cannot be fully explained, except for that it carries some genetic implication. Bearing that in mind, clinicians are tasked with keeping an active eye for pulmonary hypertension or arterial hypertension (PAH) symptoms in women, and providing proper care. How that might formulate, Gary Palmer, MD, MBA, Vice President of Medical Affairs for Actelion Pharmaceuticals and Victor Tapson, MD, Director of the Venous Thromboembolism & Pulmonary Vascular Disease Research Program at the Cedars-Sinai Medical Center, told MD Magazine®, is in additional care providers and more frequent check-ups.
Palmer and Tapson discussed the gender disaprities in patients with PH and PAH while attending the 2018 CHEST Annual Meeting in San Antonio, TX, this week.